Yellow Jersey Therapeutics AG
1 clinical trials · Sponsor
◉ Watch Yellow Jersey Therapeutics AG
| Record | Firm | Date |
|---|---|---|
| Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) (NCT05859724) | Yellow Jersey Therapeutics AG | 2023-05-10 |
Track Yellow Jersey Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.